Demo Sign up Log In

AstraZeneca PLC Ordinary Shares (AZN)

EBITDA Margin

33.56%

Quarterly · Period ending: Jun 30, 2026

AZN EBITDA Margin

Latest reported33.56%period endingJun 30, 2026

Latest reported33.56%period endingJun 30, 2026

AZN Quarterly EBITDA Margin (100.00% → 33.56%)

Quarterly ebitda margin

High-resolution chart · PNG

AZN ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares EBITDA Margin — Quarterly
Period ending	EBITDA Margin
Jun 30, 2001	28.1212%
Mar 31, 2001	32.7487%
Dec 31, 2000	19.9252%
Sep 30, 2000	31.4479%
Jun 30, 2000	31.1754%
Mar 31, 2000	30.704%
Dec 31, 1999	-11.4303%
Sep 30, 1999	27.3195%
Jun 30, 1999	28.0659%
Mar 31, 1999	100%
Dec 31, 1998	-287.052%
Sep 30, 1998	100%
Jun 30, 1998	27.2371%
Mar 31, 1998	100%
Dec 31, 1997	-192.7549%
Sep 30, 1997	100%
Jun 30, 1997	100%
Mar 31, 1997	100%
Dec 31, 1996	-62.4922%
Sep 30, 1996	100%
Jun 30, 1996	100%
Mar 31, 1996	100%
Dec 31, 1995	-269.4906%
Sep 30, 1995	100%
Jun 30, 1995	18.7754%
Mar 31, 1995	100%
Dec 31, 1994	-220.615%
Sep 30, 1994	100%
Jun 30, 1994	100%
Mar 31, 1994	100%
Dec 31, 1993	-253.9688%
Sep 30, 1993	100%
Jun 30, 1993	100%
Mar 31, 1993	100%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.